MGCD265
Detailed Description
MGCD265 is a tyrosine kinase inhibitor that selectively targets MET and Axl. Genetic alterations in these targets have been implicated as drivers of tumor growth and disease progression in NSCLC, HNSCC, gastroesophageal cancer and other solid tumors.